A platform TechBio company using Generative AI to unlock new therapeutics
PentaBind is an innovative biotechnology research company dedicated to discovering and developing groundbreaking therapeutics. Utilizing advanced Artificial Intelligence and an integrated wet-laboratory, PentaBind designs high-performance aptamers with multiple drug-like qualities in a single step. This approach allows PentaBind to create its own pipeline of therapeutic assets, leveraging aptamers both as active ingredients and as delivery vehicles.
PentaBind is supported by leading organizations such as Entrepreneur First VC, Twin Path, P4SY, Panacea Stars, Stevenage Bioscience Catalyst, Science Creates Accelerator, Science Entrepreneur Club, and KQ Labs (the Francis Crick Institute). With a focus on innovation and excellence, PentaBind is committed to making significant contributions to the field of biotechnology.
Located in London, GB, PentaBind is poised for continued growth and success. We invite the manager of PentaBind to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility and commercial opportunities.
Other organizations in the same industry
This company is also known as